What is the recommended dosage of metronidazole (Flagyl) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing in Pediatric Patients

For most pediatric infections requiring metronidazole, use 30-40 mg/kg/day divided every 8 hours (maximum 500 mg per dose), with dosing adjustments based on the specific clinical scenario. 1

Standard Dosing by Clinical Indication

General Anaerobic Infections

  • Administer 30-40 mg/kg/day divided every 8 hours, with a maximum of 500 mg per dose 1
  • The FDA-approved pediatric dosing for amebiasis is 35-50 mg/kg/24 hours divided into three doses for 10 days 2
  • For serious anaerobic infections, the adult-equivalent oral dosing is 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult) 2
  • Standard treatment duration is 7-10 days for most infections, though bone/joint, lower respiratory tract, and endocardial infections may require longer courses 2

Intra-Abdominal Infections

  • Use 30-40 mg/kg/day divided every 8 hours as part of combination therapy 1
  • Combine with aminoglycosides, carbapenems, or advanced-generation cephalosporins for complicated infections 1
  • For mixed necrotizing infections requiring anaerobic coverage, use 7.5 mg/kg/dose every 6 hours IV, typically combined with cefotaxime (50 mg/kg/dose every 6 hours) 1

Clostridioides difficile Infection (CDI)

Non-Severe CDI:

  • Administer 7.5 mg/kg/dose three or four times daily (maximum 500 mg per dose) for 10 days 3, 4
  • This dosing is LOWER than for other anaerobic infections (10-13 mg/kg/dose) 1
  • Oral vancomycin (10 mg/kg/dose four times daily, maximum 125 mg per dose) is an alternative 4

Severe or Fulminant CDI:

  • Oral vancomycin is strongly recommended over metronidazole (strong recommendation, moderate quality evidence) 3
  • If metronidazole must be used in severe infections, administer 10 mg/kg/dose three times daily IV (maximum 500 mg per dose) 3

Recurrent CDI:

  • For first recurrence after metronidazole: use oral vancomycin 10 mg/kg/dose four times daily (maximum 125 mg per dose) for 10 days 4
  • For second or subsequent recurrences: oral vancomycin is recommended over metronidazole (weak recommendation, low quality evidence) 3
  • Avoid repeated or prolonged metronidazole courses due to peripheral neuropathy risk 4

Perianal Fistulizing Crohn's Disease

  • Use 10-20 mg/kg/day in divided doses 5, 1
  • Ciprofloxacin 20 mg/kg/day is an alternative or adjunctive option 5
  • These antibiotics offer good short-term response and may bridge to immunosuppressive medications 5

Age-Specific Dosing Considerations

Neonates

  • Dosing varies significantly by postnatal age and weight 5
  • Postnatal age ≤7 days and ≤2000 g: 7.5 mg/kg every 12 hours 5
  • Postnatal age ≤7 days and >2000 g: 7.5-10 mg/kg every 12 hours 5
  • Postnatal age >7 days and <1200 g: 7.5-10 mg/kg every 8-12 hours 5
  • Postnatal age >7 days and >2000 g: 10 mg/kg every 8 hours 5

Infants and Children

  • Standard dosing: 15-22.5 mg/kg/day divided every 8 hours 5
  • Some patients may require up to 30 mg/kg/day divided every 8 hours based on serum levels (e.g., cystic fibrosis or febrile neutropenic patients) 5

Alternative Dosing Strategies

Once-Daily Dosing for Appendicitis

  • Recent pharmacokinetic data supports 30 mg/kg per dose once daily for pediatric appendicitis 6
  • This achieves AUC/MIC ratio ≥70 for Bacteroides fragilis with MIC ≤2 mcg/mL in 96-100% of patients 6
  • Target attainment decreases for higher MICs (61-97% for MIC 4 mcg/mL; 9-71% for MIC 8 mcg/mL) 6
  • This dosing strategy is based on metronidazole's long half-life, concentration-dependent killing, and 3-hour postantibiotic effect 6

Special Populations and Considerations

Malnourished Children

  • Severe malnutrition requires a 60% dose reduction to 12 mg/kg/day to avoid drug accumulation 7
  • Biotransformation is significantly impaired in malnourished children, leading to elevated plasma concentrations 7
  • This dosing maintains therapeutic plasma concentrations of 6.0 mcg/mL 7

Hepatic Impairment

  • Patients with severe hepatic disease metabolize metronidazole slowly, requiring cautious dose reduction 2
  • Close monitoring of plasma metronidazole levels and toxicity is recommended 2

Renal Impairment

  • Do not specifically reduce doses in anuric patients since accumulated metabolites are rapidly removed by dialysis 2

Route of Administration

  • Intravenous metronidazole is usually administered initially for most serious anaerobic infections 2
  • Transition to oral therapy is appropriate once clinical improvement occurs 8
  • In one study, patients received initial parenteral therapy for 5-21 days (average 11.6 days) before transitioning to oral therapy 8

Common Pitfalls and Caveats

  • Do not use the same dosing for CDI as for other anaerobic infections—CDI requires lower doses (7.5 mg/kg/dose vs. 10-13 mg/kg/dose) 1
  • Avoid metronidazole in first-trimester pregnancy (contraindicated) 2
  • Do not exceed 4 g in 24 hours regardless of indication 2
  • Monitor for peripheral neuropathy with prolonged or repeated courses 4
  • Therapeutic drug monitoring may be necessary in elderly patients, those with hepatic impairment, or malnourished children 2, 7
  • Peak concentrations on day 3 of therapy typically range from 15.2-30 mcg/mL, with trough levels of 4-11.6 mcg/mL 8

References

Guideline

Pediatric Metronidazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Clostridioides difficile Infection in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A new dosing regimen for metronidazole in malnourished children.

Scandinavian journal of infectious diseases, 1993

Research

Treatment of anaerobic infections in children with metronidazole.

Developmental pharmacology and therapeutics, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.